There were still articles out there which focused on the science, as opposed to being blinded by the asx bling-bling.
https://www.bioworld.com/articles/711460-neurens-nnv-2591-positive-in-angelman-syndrome-phase-ii-trial?v=preview
https://www.thechronicle.com.au/business/*/asx-health-stocks-neurens-angelman-drug-shows-good-results-but-share-price-drops-7pc/news-story/bd3e7b09cdd63154ced6a7819f481fed. (replace the * with the word s-t-o-c-k-h-e-a-d)
https://evrimagaci.org/tpg/neuren-leads-biotech-surge-with-angelman-drug-success-9493
Neuren Media and Analyst Coverage, page-1285
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.97 |
Change
-0.260(1.60%) |
Mkt cap ! $2.034B | |||
| Open | High | Low | Value | Volume |
| $16.33 | $16.37 | $15.85 | $5.650M | 352.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 428 | $15.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.98 | 365 | 6 |
View Market Depth
| Last trade - 12.52pm 13/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |